Compound ID | 2020
Class: Polymyxin
| Spectrum of activity: | Gram-negative |
| Details of activity: | Disrupts the outer membrane by direct interaction with the lipid A component of the LPS and and disrupts the physical integrity of the phospholipid bilayer of the inner membrane. Active against Gram-negative bacteria including Acinetobacter and Pseudomonas |
| Description: | Natural product produced by Paenibacillus polymyxa. Polymyxin B is composed of polymyxins B1, B1-I, B2, B3, and B6. Used for systemic and topical treatment of Gram-negative infections. |
| Year first mentioned: | 1947 |
| Development status: | Approved, off-patent |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5702105 |
| Guide to Pharmacology: | polymyxin B |
| Citations: |
|